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Introduction
------------

Sarcoidosis is a chronic, multisystem inflammatory disease of unknown etiology characterized by the presence of non-caseating granulomas in different organs. Although the lungs are the most common sites of inflammation, sarcoidosis can involve other organs such as the eyes (intraocular and adnexal), skin, lymph nodes, salivary glands, heart, spleen, liver, and the nervous system \[[@B1]\]. A combination of clinical, radiological, and histological criteria are used to diagnose sarcoidosis. Remarkable clinical similarities with tuberculosis (TB) make the differential diagnosis of the two conditions difficult especially in countries with high burden of tuberculosis. Negative Mantoux test and exclusion of mycobacterial infection or caseation in the biopsy specimens help in diagnosing sarcoidosis. Among the high TB endemic countries, there is increasing literature available on sarcoidosis from India. In this review, we look at the tuberculosis link, epidemiology of sarcoidosis in areas with high TB burden especially India, the emerging literature on sarcoidosis in high TB endemic areas like India, the clinical profile of sarcoidosis including the systemic and ocular features, the diagnostic modalities, and the dilemma faced in the diagnosis and treatment.

Epidemiology of sarcoidosis in areas with high TB burden
--------------------------------------------------------

Sarcoidosis was considered to be a disease seen more commonly in the west and rarely in the developing world in earlier reports. In a study from eight countries of Asia and Africa in 1976, fewer than 30 patients were reported from India, Malaysia, Thailand, Taiwan, and United Arab Emirates, while none from Singapore and Korea \[[@B2]\]. In the recent years, there has been increasing reports from countries like India \[[@B3]-[@B13]\], Singapore \[[@B14]\], Malaysia \[[@B15]\], Thailand \[[@B16]\], and Taiwan \[[@B17]\]. In all probabilities, the disease was probably overshadowed by the presence of tuberculosis. Reports have also mentioned that the increase in incidence of sarcoidosis was probably related to the decrease in infectious diseases, especially tuberculosis and the implementation of tuberculosis control programs \[[@B4]\]. However, the cases of tuberculosis are still prevalent in the developing world, but we diagnose sarcoidosis with greater frequency in recent times. Unlike in the past, this is probably due to the increased awareness of the disease and improved efforts to make a diagnosis. The availability of computed tomography and fiberoptic bronchoscopy for transbronchial lung and lymph node biopsies has made a big difference in the diagnosis of the disease \[[@B12]\].

The true burden of sarcoidosis in India is not clearly known, as reliable epidemiological data are not available. It has been estimated that sarcoidosis constituted 10 to 12 cases per 1,000 new registrations in a respiratory unit at Kolkata and 61.2/100,000 new cases at a center in New Delhi in a report published in 2002 \[[@B13]\]. The cases of sarcoidosis have been reported across the country with no data on regional or ethnic differences and are now considered routinely in the differential diagnosis of respiratory and non-respiratory diseases including ocular problems. Reports of ocular sarcoid have been reported from across the country in the recent years \[[@B8]-[@B10],[@B18]-[@B22]\].

The tuberculosis link
---------------------

Mycobacterium tuberculosis as a cause of sarcoidosis has been extensively studied in the literature \[[@B23]-[@B25]\]. Reports of previous history of contact with tuberculosis in patients with sarcoidosis \[[@B26]\], similarities in time trends in the prevalence of the two diseases, and ethnic populations with higher incidence of TB having high incidence of sarcoidosis are described in the literature \[[@B27],[@B28]\]. Studies from India reporting patients with TB preceding the development of sarcoidosis or concurrent presence of both diseases have been described \[[@B3],[@B4]\]. Molecular techniques such as nucleic acid amplification tests have demonstrated mycobacterial DNA and RNA in 30% of sarcoid biopsy tissues \[[@B5],[@B25]\]. This was 48% in a prospective study from India \[[@B5]\]. Mycobacterial proteins like *MTb* catalase peroxidase (mKatG), superoxide dismutase, mycolyl transferase, and heat shock proteins have been detected \[[@B29]\]; immune responses to them have also been detected in sarcoid tissues, blood, and bronchoalveolar lavage fluid. When interferon-gamma (IFN-γ) ELISPOT assays and flow cytometry were used to assess the lung and blood T-cell responses to mKatG in sarcoidosis patients, a higher frequency of mKatG-reactive, IFN-γ expressing T cells was demonstrated in patients with active sarcoidosis than in controls \[[@B30]-[@B33]\]. This antigen also elicited granulomatous response in animal models, renewing interest in mycobacteria as a causative agent in sarcoidosis. Studies from India have shown positivity to QuantiFERON TB gold test in a small subset of sarcoid patients \[[@B6]\].

Systemic sarcoidosis: clinical features
---------------------------------------

The course of sarcoidosis ranges from asymptomatic to severe disease. Male preponderance with a mean age of 40 years is reported in most Indian reports \[[@B3],[@B4],[@B7],[@B10]\]. Reports in ophthalmology literature from south India have shown a female preponderance \[[@B9]\].

The disease affects predominantly the lungs, thoracic lymph nodes, skin, and eyes. Clinically, patients may be asymptomatic or complain of cough or breathlessness. Constitutional symptoms such as fever, malaise, fatigue, and weight loss may be present. The most frequent intrathoracic involvement is the presence of hilar or mediastinal lymph node enlargements with or without radiologic evidence of interstitial involvement in one-third of patients. The miliary pattern can be seen in sarcoidosis and may be misdiagnosed and treated for tuberculosis \[[@B3]\]. High resolution computed tomography (CT) is more diagnostic than chest X-ray \[[@B3],[@B4],[@B22]\].

Skin involvement may include sarcoid granulomas and erythema nodosum. Bilateral parotid gland enlargement, hepatic involvement with granulomas, renal insufficiency, myocardial involvement with heart failure, hypertension and conduction abnormalities, arthropathy, neurological involvement in the form of recurrent laryngeal nerve palsy, Bells\' palsy, other cranial neuropathies and spinal chord involvement, generalized lymphadenopathy, and minor hematologic abnormalities have been reported from India \[[@B3],[@B4]\]. Sporadic reports of childhood sarcoidosis are seen in India. Those cases manifesting with generalized lymphadenopathy are mistaken for TB and are usually treated initially with antitubercular therapy \[[@B3]\].

Ocular sarcoidosis: clinical features
-------------------------------------

Patients may present directly to an ophthalmology clinic with blurred vision, floaters, redness or discomfort, or may be referred by the pulmonologists or rheumatologists for an ocular evaluation. Ocular disease may be the initial manifestation in sarcoidosis. Ocular involvement occurs in 25% to 60% of patients with systemic sarcoidosis presenting to a respiratory center \[[@B10]\]. This was around 95% in those who presented to the tertiary eye care center probably due to the referral bias \[[@B9]\]. Ocular manifestations include uveitis, dry eye, conjunctival granulomas, and involvement of the orbit and optic nerve \[[@B9],[@B10],[@B18]-[@B21],[@B34]\].

In contrast to reports from western literature \[[@B35]\], panuveitis is the most common manifestation seen in most of the reports from India. As most of the reports are from tertiary referral centers, it could be possible that initial presentations of anterior uveitis could be treated by general ophthalmologists prior to referral.

Anterior uveitis could be acute iridocyclitis or a chronic granulomatous uveitis with keratic precipitates, which may vary from cellular to large mutton fat type of keratic precipitates. Iris nodules such as the Koeppe and busacca nodules and iris granulomas may be seen. Granulomas may also be seen in the trabecular meshwork causing increase in intraocular pressure at the time of activity. Intermediate uveitis with vitritis, peripheral vasculitis, snowball opacities, and snow banking have been described in reports from India as well. Posterior segment involvement includes periphlebitis with characteristic 'candle wax dripping appearances' , multifocal chorioretinitis, peripheral punched out chorioretinal lesions, choroid and optic nerve granulomas, optic disc edema, papilledema, optociliary shunts, and arterial macro aneurysms. Rare manifestations of scleral nodule, vasoproliferative tumors, and retinitis have also been reported from India. Conjunctival granulomas, bilateral lacrimal gland enlargement, and orbital mass lesions have been reported from India \[[@B9],[@B34]\]. Illustrations are provided as Figures  [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"} , [8](#F8){ref-type="fig"} , [9](#F9){ref-type="fig"}, [10](#F10){ref-type="fig"}, [11](#F11){ref-type="fig"}, [12](#F12){ref-type="fig"}, [13](#F13){ref-type="fig"}, [14](#F14){ref-type="fig"}, and [15](#F15){ref-type="fig"}.
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![Slit lamp photograph showing the granulomatous anterior uveitis with large Koeppe nodules.](1869-5760-3-53-3){#F3}
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![Fundus photograph showing the choroidal granulomas.](1869-5760-3-53-8){#F8}

![Fundus photograph showing the peripheral chorioretinal punched out scars in a patient with sarcoidosis.](1869-5760-3-53-9){#F9}

![Fundus photograph showing the optic nerve head anastomosis in a patient with cutaneous sarcoidosis.](1869-5760-3-53-10){#F10}

![High resolution computed tomography of the orbits showing bilateral lacrimal gland enlargement.](1869-5760-3-53-11){#F11}

![Chest X-ray showing bilateral hilar lymphadenopathy in a patient with sarcoidosis.](1869-5760-3-53-12){#F12}

![High resolution computed tomography of the thorax showing mediastinal lymphadenopathy in a patient with grade 2 sarcoid with respiratory symptoms.](1869-5760-3-53-13){#F13}

![External photograph of sarcoid granuloma on the face.](1869-5760-3-53-14){#F14}

![Photomicrograph of biopsy from lacrimal glands showing non-caseating granulomas with giant cells.](1869-5760-3-53-15){#F15}

Diagnostic modalities
---------------------

A negative Mantoux (PPD) skin test is considered to suggest sarcoidosis and is usually seen in 90% of sarcoid patients \[[@B36]\]. Elevated serum angiotensin converting enzyme is elevated in only half the patients with sarcoidosis and may be also seen in tuberculosis and, hence, nonspecific. Bronchoalveolar lavage and gallium citrate scanning is also nonspecific and may be positive in tuberculosis as well.

High resolution CT is of great help in making the diagnosis of sarcoidosis by detecting interstitial involvement and lymphadenopathy. Contrast-enhanced CT may help distinguish sarcoid from tubercular lymph node enlargement, which would usually show a central hypodensity corresponding to the caseation and peripheral contrast enhancement. The frequent use of fiberoptic bronchoscopy with transbronchial lymph node and endobronchial lung biopsies with diagnostic yield of about 80% have helped in the recognition of sarcoidosis. Microbiology (smear and culture for MTB) and histopathology are routinely done on the aspirates/biopsy material to rule out TB.

The sarcoid-TB dilemma
----------------------

Both TB and sarcoid share remarkable similarities in their clinical and radiological presentations. Both diseases present with constitutional symptoms of fever, malaise, weight loss, and fatigue. Respiratory symptoms are common to both diseases. Similar ocular manifestations are seen in both diseases. Serpiginous-like choroiditis in the Indian subcontinent are more likely to be associated with tuberculosis \[[@B37]\]; however, rare case reports of sarcoidosis presenting with an APMPPE-like manifestation have also been reported \[[@B35]\]. Dry eye, bilateral lacrimal gland enlargements are more common in sarcoidosis, though latter have been reported in TB also \[[@B38]\]. In a study conducted by us in patients with biopsy-proven granulomatous uveitis, we reported that the likelihood ratio of the uveitis being tubercular is around 76.6%, if a combination of pigmented multifocal choroiditis patches along the retinal blood vessels, a Schirmer test ≥ 10 mm, and a positive Mantoux test are present \[[@B8]\].

Radiologic similarities may be seen in both diseases. Discrete, bilateral, symmetrical lymph node enlargement is usually seen in sarcoidosis. Fibrosis and military distribution although common in TB may be seen in both diseases. Both diseases show granulomatous inflammation on histopathology. Caseation is seen in tuberculosis. Fibrinoid necrosis though rare can occur in up to 30% of cases of sarcoidosis. There are no specific features enough to differentiate the two conditions with certainty, except a positive culture of MTb. A positive PCR for MTb may be seen in the biopsy samples of sarcoidosis.

Differentiating the two conditions pose a challenge, particularly in countries with high prevalence of TB. A combination of clinical, radiologic, and laboratory tests are used to make a diagnosis of sarcoidosis. Tuberculin skin test plays an important role in the diagnosis \[[@B36]\]. Tuberculin anergy is a clinically important phenomenon in sarcoidosis. As a negative tuberculin test excludes TB except in immunosuppressed or extremely sick individuals, we do attach a great deal of importance to this test. On the other hand, patients with positive interferon-γ release assays (IGRA) are sometimes misdiagnosed as TB. A recent study from India shows positive interferon-γ release assay in some patients with sarcoidosis. Thus, in countries with high TB burden, one must not make a diagnosis of TB on the basis of positive IGRA alone \[[@B6]\].

Treatment
---------

Corticosteroids are the mainstay of treatment in sarcoidosis. In chronic cases or in those patients were steroids are contraindicated, immunosuppressants like methotrexate, azathioprine, mycophenolate mofetil, cyclosporine, and cyclophosphamide have been used \[[@B39],[@B40]\]. Methotrexate has been used most frequently, as it is cost effective. Aggressive cases may even require intravenous methyl prednisolone or pulse intravenous cyclophosphamide. Use of biologics like rituximab \[[@B41]\] in steroid-resistant cases of sarcoid has been reported. Many times, patients are treated with antitubercular therapy prior to the diagnosis of sarcoid.

Conclusions
===========

Diagnosing sarcoid in countries with high TB burden does pose a significant challenge. However, new cases of sarcoid are increasingly diagnosed in TB endemic areas in recent years due to increased awareness and better availability of diagnostic modalities. Ocular evaluations do contribute in making a diagnosis of systemic sarcoid. Negative Mantoux test is still being considered an important diagnostic test to make a diagnosis. Sarcoidosis does exist in populations with high TB burden, and the association between sarcoid and TB continues to be an enigma. Prospective studies from the Indian continent on the epidemiological data, genotypic and phenotypic variations, and the role of mycobacteria in the development of sarcoidosis would contribute a great deal in understanding this disease.
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